Report: Wellpoint targets breast cancer patients with policy rescissions

Reuters, in an exclusive report about the insurance industry practice of rescission: "That tens of thousands of Americans lost their health insurance shortly after being diagnosed with life-threatening, expensive medical conditions has been well documented by law enforcement agencies, state regulators and a congressional committee. Insurance companies have used the practice. ... And a congressional committee last year said WellPoint was one of the worst offenders. But WellPoint also has specifically targeted women with breast cancer for aggressive investigation with the intent to cancel their policies, federal investigators told Reuters" (Waas, 4/22).

USA Today On Deadline: The news service reports, citing federal investigators and regulators, that "WellPoint, the nation's largest insurer, has aggressively targeted women with breast cancer with the intent of canceling their health insurance policies. ... The insurer has used a computer program to automatically trigger fraud investigations despite any evidence of wrongdoing." The Reuters article focuses on the cases of three specific women whose policies were cancelled (Winter, 4/22).

WellPoint posted a response to the Reuters article on PR Newswire.


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered tool predicts gene activity in cancer cells from biopsy images